Clinical Report: Extended Ex-Situ Heart Perfusion Maintains Cardiac Function
Overview
Expand on the implications of maintaining cardiac function for donor organ utilization.
Background
Heart transplantation faces significant limitations due to a shortage of viable donor organs and the constraints of static cold storage, which allows only 4-6 hours of safe ischemic time. This short window often leads to the discard of otherwise suitable grafts. Normothermic ESHP presents a promising alternative, potentially enhancing graft viability and expanding the donor pool.
Data Highlights
Parameter
Baseline
Post-Transplant (0h)
Post-Transplant (4h)
Cardiac Output (L/min)
5.94 ± 0.16
6.78 ± 0.12
7.06 ± 0.16
Oxygen Consumption (mL/min/m²)
—
—
172.88 ± 7.60
Lactate Levels
Low
Low
Low
Key Findings
Hearts preserved for 24 hours on the ECMO-based ESHP system maintained adequate hemodynamic function post-transplant.
Cardiac output significantly increased from baseline to 4 hours post-transplantation (p = 0.017).
Oxygen consumption increased significantly at 4 hours post-transplantation (p = 0.0322 vs. donor).
No acute graft dysfunction was observed in any of the transplanted hearts.
Despite reductions in hemoglobin and arterial oxygen content, oxygen delivery remained adequate.
Clinical Implications
The findings suggest that prolonged normothermic preservation of donor hearts using ESHP can enhance graft viability and function, potentially reducing organ discard rates. This approach may facilitate the use of marginal grafts, including those from donation after circulatory death.
Conclusion
Highlight implications for clinical practice and suggest areas for future research.
